Development of Competency-based Online Genomic Medicine Training (COGENT).

IF 1.7 4区医学 Q3 PHARMACOLOGY & PHARMACY

Personalized medicine Pub Date : 2023-01-01 Epub Date: 2022-11-23 DOI:10.2217/pme-2022-0101

Susanne B Haga, Wendy K Chung, Luis A Cubano, Timothy B Curry, Philip E Empey, Geoffrey S Ginsburg, Kara Mangold, Christina Y Miyake, Siddharth K Prakash, Laura B Ramsey, Robb Rowley, Carolyn R Rohrer Vitek, Todd C Skaar, Julia Wynn, Teri A Manolio

引用次数: 0

Abstract

The fields of genetics and genomics have greatly expanded across medicine through the development of new technologies that have revealed genetic contributions to a wide array of traits and diseases. Thus, the development of widely available educational resources for all healthcare providers is essential to ensure the timely and appropriate utilization of genetics and genomics patient care. In 2020, the National Human Genome Research Institute released a call for new proposals to develop accessible, sustainable online education for health providers. This paper describes the efforts of the six teams awarded to reach the goal of providing genetic and genomic training modules that are broadly available for busy clinicians.

查看原文本刊更多论文

基于能力的在线基因组医学培训(COGENT)的发展。

通过新技术的发展，遗传学和基因组学领域已经大大扩展到医学领域，这些新技术已经揭示了遗传对一系列广泛的特征和疾病的贡献。因此，为所有医疗保健提供者开发广泛可用的教育资源对于确保及时和适当地利用遗传学和基因组学患者护理至关重要。2020年，美国国家人类基因组研究所(National Human Genome Research Institute)发布了一项呼吁，要求提出新的建议，为卫生服务提供者开发可访问的、可持续的在线教育。本文描述了六个获奖团队的努力，以实现为忙碌的临床医生提供广泛可用的遗传和基因组培训模块的目标。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Personalized medicine 医学-药学

CiteScore

3.30

自引率

4.30%

发文量

审稿时长

6-12 weeks

期刊介绍： Personalized Medicine (ISSN 1741-0541) translates recent genomic, genetic and proteomic advances into the clinical context. The journal provides an integrated forum for all players involved - academic and clinical researchers, pharmaceutical companies, regulatory authorities, healthcare management organizations, patient organizations and others in the healthcare community. Personalized Medicine assists these parties to shape thefuture of medicine by providing a platform for expert commentary and analysis. The journal addresses scientific, commercial and policy issues in the field of precision medicine and includes news and views, current awareness regarding new biomarkers, concise commentary and analysis, reports from the conference circuit and full review articles.